Chris is currently a first year MBA at Harvard Business School. Chris grew up in a tightly knit Midwestern family before attending college. After receiving his BS in Biomedical Engineering from Duke, Chris moved to Boston for to work for Covidien and has been here ever since. At Covidien, Chris worked in product development on hemostatic agents and drug delivery vehicles before moving on to Arsenal Medical working on Res-Q-Foam, a project designed for DARPA to save military lives. Chris is passionate about translating bench-top technologies to impactful clinical therapies.